Lilly Sues Generics Maker Over Zyprexa Patent

Law360, New York (April 4, 2011, 10:12 PM EDT) -- Eli Lilly & Co. sued Accord Healthcare Inc. Monday, hoping to hinder the North Carolina pharmaceutical company's efforts to market a generic version of Lilly's schizophrenia drug Zyprexa.

Lilly launched a patent infringement suit in the U.S. District Court for the Middle District of North Carolina after learning that Accord had filed an abbreviated new drug application with the U.S. Food and Drug Administration to sell 2.5, 5, 7.5, 10, 15 and 20 milligram generic Zyprexa tablets.

The suit claims that Accord filed its ANDA to...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.